SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Discussion centers on Midnights mainnet launch and reported Coinbase listing, with traders also highlighting Google Cloud and Vodafone validator participation as signs of growing reach. Supporters see adoption momentum, while skeptics point to ongoing token-selling pressure and question whether the developments will translate into sustained demand.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cashs sharp rallies and pullbacks are driving the discussion, with traders citing CME futures access and a Grayscale filing as possible catalysts for an earlier breakout. Bulls point to BCHs relative strength and the planned CashVM upgrade, while skeptics question its utility and warn that momentum could fade.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs spectrum acquisition and Starlink Mobile plans to become a wireless carrier have fueled concern that T-Mobile could face greater long-term competition, contributing to a sharp selloff in telecom stocks. Traders are divided between viewing SpaceX as a future threat and calling the reaction excessive because building a competitive terrestrial network would require substantial investment and time.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRXs high-volume rally is being linked to anticipation of founder Patrick Soon-Shiongs Piper Sandler oncology symposium chat, where he is expected to discuss trial progress; traders are also watching for updates on bladder-cancer programs and international expansion. Some bullish posts speculate about a partnership or short squeeze, but those claims remain unverified.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

IOVAs rally is drawing attention amid the companys higher revenue outlook and expectations for upcoming melanoma, sarcoma and lung-cancer updates. Traders also point to a reported decline in short interest as a possible source of buying pressure, while others warn that the sharp run-up could give way to volatility and debate whether the NSCLC update will arrive on schedule.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, and Defense. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Recent weakness has prompted frustration and debate despite continued discussion of Rolls-Royces aerospace and defense prospects, Indias proposed AMCA engine partnership, and small-reactor opportunities. Traders are divided between viewing the pullback as a buying opportunity and questioning the stocks near-term momentum; an anticipated hyperscaler deal remains speculation.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Goldman Sachs Buy upgrade, citing Palantirs sovereign-AI and customized-software growth opportunities, is fueling attention alongside a breakout to new highs. Bulls are celebrating the momentum and speculating about a short squeeze, while skeptics argue the valuation is stretched and warn of a pullback.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Uncertainty over NASAs delayed CLPS 2.0 lunar-contract awards is the main focus, with traders watching for a decision and debating whether Intuitive Machines could benefit. Bulls view a contract as a potential catalyst, while bears point to repeated delays, a persistent downtrend, and weakness across space stocks.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY is drawing attention amid weak price performance and concerns about exchange delistings, with traders debating whether the listing changes are materially bearish or being overstated. Bulls point to JasmyChain activity and ecosystem developments as potential sources of utility, while critics question whether meaningful adoption has emerged.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is being linked to its Nasdaq-100 reentry and resulting index-fund buying, as well as optimism around the NIHs planned cancer-vaccine initiative and the companys personalized cancer-vaccine program with Merck. Bulls see potential in the oncology pipeline, while skeptics question the valuation and profitability and attribute part of the move to index flows or short covering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$JNJ Johnson &amp; Johnson (NYSE: JNJ) heads into October 13 earnings with a higher annual outlook. Explore the growth and margin signals that could support its momentum. https://biotechhealthx.com/biotech-news/johnson-johnson-jnj-raised-the-bar-and-earnings-will-test-it/

Johnson & Johnson (NYSE: JNJ) heads into October 13 earnings with a higher annual outlook. Explore the growth and margin signals that could support its momentum.

BioTech Health X

Johnson & Johnson (JNJ) Raised the Bar and Earnings Will Test It

StockTwits Web

Johnson & Johnson

 Johnson & Johnson (NYSE: JNJ) heads into October 13 earnings with a higher annual outlook. Explore the growth and margin signals that could support its momentum. 